MessagingLab
Publishers of Karl Schmieder's Bio-Marketing Newsletter
Home
MessagingLab
Bio-Marketing Newsletter
Contact Us
Survey
Posts from the ‘Biotechnology’ Category
0
3.2.10
Infoneuron Overload Unit
0
2.25.10
Crush It! Reviewed
0
2.23.10
02.22.2010 – Beaker Beat – Video Games for Pharma Marketing?
0
2.19.10
Attended: What’s New/Next for the Biopharmaceutical Industry?
0
2.15.10
02.15.2010 Beaker Beat – FDA Wants More $$$
0
2.9.10
02.08.2010 BeakerBeat – The FDA Needs Your Help Edition
0
2.8.10
Xconomy’s Biotech Predictions for 2010-2020
0
2.3.10
Attended: Venture Capital Lunch Club 2010
0
1.13.10
1.11.10 BeakerTV – Welcome to Our Company. Now, Goodbye.
0
1.6.10
Looking Back – Roche’s 2009 Acquisition of Genentech
« Older Entries
Archives
Select Month
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
July 2008
June 2008
August 2007
July 2007
June 2007
February 2007
November 2006
June 2006
February 2006
January 2006
December 2005
November 2005
June 2005
May 2005
April 2005
March 2005
February 2005
July 8
Search
KarlS_mLab on Twitter
HBR: 2 minute opportunity test for entrepreneurs
http://bit.ly/9J5Rxu
about 13 hours ago
from
HootSuite
NYT: Poet Lisa Russ Spaar on something I can relate to: Insomnia. Beautifully written and worth reading:
http://nyti.ms/9EEJUP
about 18 hours ago
from
HootSuite
So, what does the Merck purchase of Milipore really mean? More, faster access to discovery technologies. Expect more analysis this week.
05:05:06 PM March 09, 2010
from
HootSuite
Ideas for fixing the communication of science
http://bit.ly/arUqk8
05:05:05 PM March 08, 2010
from
HootSuite
Church of the Customer: Loyalty lessons from Lady Gaga (who's songs are constantly spinning in my head)
http://bit.ly/dvWIHN
05:04:50 PM March 06, 2010
from
HootSuite
View my LinkedIn profile
Blogroll
BioPharma Today
BioSpace
Biotech Blog
Dose of Digital
FierceBiotech
FiercePharma
Future of Biomolecules
Future Pundit
Impactiviti
Pharma 2.0
Pharma Marketing Blog
Pharma Strategy Blog